As <a href="https://www.theedgesingapore.com/tags/parkway-life-reit-plife-reit" target="_blank">Parkway Life REIT</a> registered another quarter of growth in the 2QFY2021 ended June, CGS-CIMB Research analysts Lock Mun Yee and Eing Kar Mei have kept “add” on the REIT with an unchanged target price of $5.05.

<hr/>See: <a href="https://www.theedgesingapore.com/capital/results/parkway-life-reit-posts-07-higher-2q21-dpu-338-cents-4-higher-1h21-dpu-695-cents" target="_blank">Parkway Life REIT posts 0.7% higher 2Q21 DPU of 3.38 cents; 4% higher 1H21 DPU of 6.95 cents</a><hr/>

The REIT’s 1HFY2021 distribution per unit (DPU) of 6.95 cents stood within their expectations at 49.2% of their FY2021 forecast, they write in a July 27 report.

The analysts have also kept their DPU estimates for the FY2021 to FY2023 unchanged.

“We like Parkway Life REIT for its stability, backed by its defensive income structure with inbuilt escalation features,” they write.

“Potential re-rating catalysts include accretive acquisitions, while downside risks include deflationary periods, whereby Singapore rent revisions would revert to 1%,” they add.

For more stories about where the money flows, <a href="https://www.theedgesingapore.com/section/capital" target="_blank">click here</a> for our Capital section

In addition, Lock and Eing say they expect to see a h-o-h increase in the REIT’s Japan rental income from its recent purchases of two nursing homes in July.

“These properties are expected to add $3.2 million (around 6.6%) of gross rental income to Parkway Life REIT’s Japan income stream. Parkway Life REIT’s balance remains robust with a gearing of 37% at end 2QFY2021 and weighted average debt maturity of 4.1 years. Assuming a 45% gearing limit, Parkway Life REIT has further debt headroom of $292.4 million to fund potential new purchases,” they say.

Units in Parkway Life REIT closed flat at $4.69 on July 28, or 2.38 times P/BV, according to CGS-CIMB’s estimates.

Accretive acquisitions may boost Parkway Life REIT’s share price: CGS-CIMB

Singapore and Hong Kong markets show latent strength  

Metro's net profit falls 35% in FY2022 on impairment loss 

Singtel posts net profit of $1.95 billion in FY2022

Leaning into innovation to bring newfound speed and accuracy to credit risk modelling 

Nearly three-quarters of Singapore workers feel prepared to adapt to change 

Adtech's growing importance in Southeast Asia's business ecosystem

Econ Healthcare posts $1.26 mil loss for 2HFY2022 after losing $3.4 mil on Crosstech exit

Accretive acquisitions may boost Parkway Life REIT’s share price: CGS-CIMB

Related Stories

Highlights

Singtel posts net profit of $1.95 billion in FY2022

Related Stories

CGS-CIMB maintains buy on GVT, but trims target price

More solid earnings recovery expected for the rest of the year, analysts maintain positive on CDL

Singtel expected to meet FY2022 estimates: CGS-CIMB